©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 109375
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.109375
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.109375
Table 6 Postoperative complications, n (%)
| Parameters | Sevoflurane group (n = 103) | Propofol group (n = 101) | t/χ2 | P value |
| Patients with no complications | 35 (33.98) | 42 (41.58) | 1.255 | 0.263 |
| Clavien-Dindo classification of complication severity | 1.965 | 0.854 | ||
| I | 12 (11.65) | 8 (7.92) | ||
| II | 42 (40.78) | 36 (35.64) | ||
| IIIa | 28 (27.18) | 33 (32.67) | ||
| IVa | 8 (7.77) | 10 (9.9) | ||
| IVb | 5 (4.85) | 6 (5.94) | ||
| V | 8 (7.77) | 8 (7.92) | ||
| CCI of complication severity | 19.85 ± 2.50 | 20.40 ± 2.55 | 1.550 | 0.123 |
- Citation: Wang Z, Cheng JW, Yu KY. Short-term and long-term effects of sevoflurane inhalation vs propofol total intravenous anesthesia in gastrectomy for gastric cancer. World J Gastrointest Oncol 2025; 17(11): 109375
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/109375.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.109375